Timing of antiretroviral therapy initiation after diagnosis of recent human immunodeficiency virus infection and CD4+ T-cell recovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Timing of antiretroviral therapy initiation after diagnosis of recent human immunodeficiency virus infection and CD4+ T-cell recovery

Published:2016-03 Issue:3 Volume:22 Page:290.e5-290.e8
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Ding Y.,Duan S.,Wu Z.,Ye R.,Yang Y.,Yao S.,Wang J.,Xiang L.,Jiang Y.,Lu L.,Jia M.,Detels R.,He N.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. Initiation of ART in early asymptomatic HIV infection;Lundgren;N Engl J Med,2015

2. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration;Lewden;Int J Epidemiol,2012

3. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection;Kaufmann;AIDS,2000

4. Enhanced CD4+ T-cell recovery with early HIV-1 antiretroviral therapy;Le;N Engl J Med,2013

5. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection;Fiebig;AIDS,2003

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Early Detection of HIV in Tajikistan;Viruses;2024-06-23

2. Effectiveness of four antiretroviral regimens for treating people living with HIV;PLOS ONE;2020-09-28

3. Determinants of suboptimal CD4 + T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection;Journal of the International AIDS Society;2020-09

4. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection;AIDS;2019-07-01

5. Immediate antiviral therapy for HIV-infected persons faces with various obstacles;Drug Discoveries & Therapeutics;2019-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3